Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018
Tag: Luigi Aurisicchio
Applied DNA Sciences is now BNB Plus Corporation, and our strategy is evolving with a new strategic focus on digital asset treasury management of BNB.
Our new ticker symbol is ‘BNBX’. Learn more here.